Zobrazeno 1 - 10
of 38
pro vyhledávání: '"V. Stoppino"'
Autor:
N. Della Valle, V. De Francesco, Enzo Ierardi, Nicola Muscatiello, Carmine Panella, Annacinzia Amoruso, V. Stoppino
Publikováno v:
Alimentary Pharmacology & Therapeutics. 19:993-998
Summary Background : A novel 10-day sequential treatment regimen recently achieved a significantly higher eradication rate than standard 7-day therapy in both peptic ulcer disease and non-ulcer dyspepsia. Its higher performance has recently been conf
Autor:
V. Stoppino, Marcella Margiotta, Carmine Panella, Antonio Francavilla, Pasquale Berloco, S. Morini, Enzo Ierardi, S. Marangi, M.F. Minenna, A. Di Leo, Francesco Russo, Michele Barone, O. Burattini, Angelo Zullo, V. De Francesco
Publikováno v:
Alimentary Pharmacology & Therapeutics. 19:407-414
Summary Background : Predicting factors for the outcome of conventional Helicobacter pylori triple therapy have been identified. Of these, the presence of the CagA gene is a strong predictor of successful treatment. Our preliminary data show that thi
Autor:
S. Winn, Cesare Hassan, Angelo Zullo, V. De Francesco, V. Stoppino, Adolfo Francesco Attili, V. Rinaldi, D. Faleo
Publikováno v:
Alimentary Pharmacology & Therapeutics. 13:163-168
Background: It has been suggested that short-term triple therapy comprising a proton pump inhibitor, plus clarithromycin and amoxycillin be used as first choice in treating H. pylori infection, while eradication failure patients should be further tre
Autor:
Silvio Danese, Marcello Picchio, E. Capezzuto, G. Stoppino, S. Fiorella, G. Pianese, Giovanni Brandimarte, Antonio Tursi, R. Lattanzio, S. Rodino, V. Stoppino, A. Spadaccini, Walter Elisei, F. Polimeni, N. Polimeni, T. D'Amico, Fabio Aiello, Piero Portincasa, N. Sacca, G. Forti, GianMarco Giorgetti
Publikováno v:
Alimentary pharmacologytherapeutics. 38(7)
Summary Background Placebo-controlled studies in maintaining remission of symptomatic uncomplicated diverticular disease (SUDD) of the colon are lacking. Aim To assess the effectiveness of mesalazine and/or probiotics in maintaining remission in SUDD
Autor:
V, De Francesco, N, Della Valle, V, Stoppino, A, Amoruso, N, Muscatiello, C, Panella, E, Ierardi
Publikováno v:
Alimentary pharmacologytherapeutics. 19(9)
A novel 10-day sequential treatment regimen recently achieved a significantly higher eradication rate than standard 7-day therapy in both peptic ulcer disease and non-ulcer dyspepsia. Its higher performance has recently been confirmed using a halved
Autor:
S. Winn, Cesare Hassan, A. Zullo, M.F. Minenna, V. De Francesco, V. Stoppino, Carmine Panella, N. Della Valle, Enzo Ierardi, Rosa Monno, L. Pietrini, S. Morini
Background and aim. One-week triple therapy for Helicobacter pylori revealed, during these last few years, a decrease in the eradication rate, so that the prolongation of its duration has been proposed. A sequential scheme recently showed very satisf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beae234c2434114b000ee244ce10741b
http://hdl.handle.net/10807/34670
http://hdl.handle.net/10807/34670
Autor:
Nicola Muscatiello, Rosario Cuomo, Marco Gentile, Carmine Panella, P. Tonti, Enzo Ierardi, Vincenzo De Francesco, V. Stoppino
Publikováno v:
Journal of clinical gastroenterology. 37(5)
Solitary ulcer syndrome (SUS) is a rare disorder that may provoke hematochezia. Argon plasma coagulation (APC) is used in a wide range of gastrointestinal bleeding. We experienced APC in a patient with a bleeding gigantic SUS: a 64-year-old woman who
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 32(8)
Publikováno v:
Journal of Clinical Gastroenterology. 29:290-291
Autor:
Angelo Zullo, Francesco Russo, Laura Troiani, Francesca Stella, Cesare Hassan, S. Marangi, Vincenzo De Francesco, O. Burattini, Sergio Morini, Alfredo Di Leo, Marcella Margiotta, V. Stoppino, Carmine Panella, Enzo Ierardi, Rosa Monno
Publikováno v:
Scopus-Elsevier
Three point mutations (A2143G, A2142G, and A2142C) have been involved in Helicobacter pylori clarithromycin resistance.To compare the eradication rates among the different point mutations and the efficacy of triple therapy and a sequential regimen ac